The paradox of muscle hypertrophy in muscular dystrophy
- PMID: 22239881
- PMCID: PMC5951392
- DOI: 10.1016/j.pmr.2011.11.014
The paradox of muscle hypertrophy in muscular dystrophy
Abstract
Mutations in the dystrophin gene cause Duchenne and Becker muscular dystrophy in humans and syndromes in mice, dogs, and cats. Affected humans and dogs have progressive disease that leads primarily to muscle atrophy. Mdx mice progress through an initial phase of muscle hypertrophy followed by atrophy. Cats have persistent muscle hypertrophy. Hypertrophy in humans has been attributed to deposition of fat and connective tissue (pseudohypertrophy). Increased muscle mass (true hypertrophy) has been documented in animal models. Muscle hypertrophy can exaggerate postural instability and joint contractures. Deleterious consequences of muscle hypertrophy should be considered when developing treatments for muscular dystrophy.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures







Similar articles
-
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.Skelet Muscle. 2016 Apr 4;6:14. doi: 10.1186/s13395-016-0085-7. eCollection 2016. Skelet Muscle. 2016. PMID: 27047655 Free PMC article.
-
Somatic mosaicism of a point mutation in the dystrophin gene in a patient presenting with an asymmetrical muscle weakness and contractures.Neuromuscul Disord. 2003 May;13(4):317-21. doi: 10.1016/s0960-8966(02)00285-7. Neuromuscul Disord. 2003. PMID: 12868501
-
Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.J Cell Biol. 2001 Mar 19;152(6):1207-18. doi: 10.1083/jcb.152.6.1207. J Cell Biol. 2001. PMID: 11257121 Free PMC article.
-
Dystrophin deficiency, altered cell signalling and fibre hypertrophy.Neuromuscul Disord. 1994 Jul;4(4):305-15. doi: 10.1016/0960-8966(94)90066-3. Neuromuscul Disord. 1994. PMID: 7981587 Review.
-
Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Physiol Rev. 2016 Jan;96(1):253-305. doi: 10.1152/physrev.00007.2015. Physiol Rev. 2016. PMID: 26676145 Free PMC article. Review.
Cited by
-
Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss.Sci Rep. 2020 Oct 14;10(1):17248. doi: 10.1038/s41598-020-74192-9. Sci Rep. 2020. PMID: 33057110 Free PMC article.
-
The inflammatory response, a mixed blessing for muscle homeostasis and plasticity.Front Physiol. 2022 Nov 23;13:1032450. doi: 10.3389/fphys.2022.1032450. eCollection 2022. Front Physiol. 2022. PMID: 36505042 Free PMC article. Review.
-
The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy.J Clin Med. 2019 May 10;8(5):649. doi: 10.3390/jcm8050649. J Clin Med. 2019. PMID: 31083420 Free PMC article. Review.
-
Muscle structure influences utrophin expression in mdx mice.PLoS Genet. 2014 Jun 12;10(6):e1004431. doi: 10.1371/journal.pgen.1004431. eCollection 2014 Jun. PLoS Genet. 2014. PMID: 24922526 Free PMC article.
-
Aberrant myonuclear domains and impaired myofiber contractility despite marked hypertrophy in MYMK-related, Carey-Fineman-Ziter Syndrome.Acta Neuropathol Commun. 2024 May 24;12(1):80. doi: 10.1186/s40478-024-01783-2. Acta Neuropathol Commun. 2024. PMID: 38790073 Free PMC article.
References
-
- Tyler KL. Origins and early descriptions of “Duchenne muscular dystrophy”. Muscle Nerve. 2003;28:402–22. - PubMed
-
- Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1998;51:919–28. - PubMed
-
- Malhotra S, Hart K, Klamut H, et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988;242:755–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous